X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (420) 420
cardiac & cardiovascular systems (308) 308
male (256) 256
female (252) 252
middle aged (213) 213
aged (179) 179
treatment outcome (166) 166
index medicus (164) 164
stents (134) 134
cardiovascular (115) 115
angioplasty (97) 97
time factors (90) 90
peripheral vascular disease (88) 88
thrombosis (88) 88
abridged index medicus (81) 81
cardiology and cardiovascular medicine (80) 80
drug therapy (78) 78
internal medicine (77) 77
heart attacks (75) 75
platelet aggregation inhibitors - therapeutic use (75) 75
stent (74) 74
angioplasty, balloon, coronary (72) 72
drug-eluting stents (72) 72
risk factors (69) 69
cardiology (65) 65
care and treatment (64) 64
mortality (64) 64
coronary angiography (63) 63
double-blind method (61) 61
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (60) 60
follow-up studies (59) 59
cardiovascular disease (58) 58
hematology (58) 58
prospective studies (56) 56
drug therapy, combination (53) 53
percutaneous coronary intervention (53) 53
clinical trials (50) 50
implantation (50) 50
platelet aggregation inhibitors - administration & dosage (48) 48
coronary vessels (47) 47
abciximab (46) 46
coronary disease - therapy (46) 46
adult (45) 45
coronary artery disease - therapy (45) 45
clinical outcomes (43) 43
myocardial infarction (43) 43
restenosis (43) 43
analysis (42) 42
myocardial infarction - therapy (42) 42
outcomes (41) 41
acute coronary syndromes (40) 40
antibodies, monoclonal - therapeutic use (40) 40
prognosis (40) 40
disease (39) 39
myocardial infarction - drug therapy (38) 38
transluminal angioplasty (38) 38
randomized controlled trials as topic (37) 37
cardiac patients (36) 36
medicine, general & internal (36) 36
prosthesis design (36) 36
acute myocardial-infarction (35) 35
coronary heart disease (35) 35
follow-up (35) 35
risk assessment (35) 35
heart attack (33) 33
immunoglobulin fab fragments - therapeutic use (33) 33
united states (33) 33
angioplasty, balloon, coronary - adverse effects (32) 32
intervention (32) 32
platelet aggregation inhibitors - adverse effects (32) 32
everolimus (31) 31
metaanalysis (31) 31
unstable angina (31) 31
dosage and administration (30) 30
myocardial-infarction (30) 30
patient outcomes (30) 30
trial (30) 30
electrocardiography (29) 29
revascularization (29) 29
usage (29) 29
artery-disease (28) 28
dose-response relationship, drug (28) 28
myocardial infarction - mortality (28) 28
safety (28) 28
blood platelets (27) 27
diabetes (27) 27
risk (27) 27
ticlopidine - analogs & derivatives (27) 27
drug-eluting stent (26) 26
ischemia (26) 26
randomized trial (26) 26
therapy (26) 26
thrombolytic therapy (26) 26
angioplasty, balloon, coronary - methods (25) 25
clopidogrel (25) 25
aged, 80 and over (24) 24
coronary artery disease (24) 24
myocardial infarction - etiology (24) 24
myocardial infarction - prevention & control (23) 23
aspirin (22) 22
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 17, pp. 1609 - 1620
Journal Article
The American Journal of Cardiology, ISSN 0002-9149, 1998, Volume 82, Issue 10, pp. 1259 - 1272
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 59, Issue 25, pp. 2344 - 2353
Objectives The primary objective of this study was to evaluate the low-density lipoprotein cholesterol (LDL-C)–lowering efficacy of 5 SAR236553/REGN727... 
Cardiovascular | Internal Medicine | statin | low-density lipoprotein cholesterol | safety | apolipoprotein-B | PCSK9 | SAR236553/REGN727 | hypercholesterolemia | CUTANEOUS VASCULITIS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | CHOLESTEROL | CARDIOVASCULAR OUTCOMES | LOW-DENSITY-LIPOPROTEIN | PREVENTION | REDUCTION | DISEASE | 14 RANDOMIZED-TRIALS | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Proprotein Convertases - antagonists & inhibitors | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Time Factors | Pyrroles - administration & dosage | Heptanoic Acids - administration & dosage | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - blood | Double-Blind Method | Proprotein Convertases - metabolism | Treatment Outcome | Anticholesteremic Agents - adverse effects | Drug Synergism | Atorvastatin Calcium | Anticholesteremic Agents - therapeutic use | Antibodies, Monoclonal - administration & dosage | Anticholesteremic Agents - administration & dosage | Aged | Serine Endopeptidases - metabolism | Proprotein Convertase 9 | Care and treatment | Serine | Low density lipoproteins | Antibodies | Thrombin | Lipoprotein A | Cholesterol | Cardiovascular agents | Antilipemic agents | Viral antibodies | Complications and side effects | Hypercholesterolemia | Proteases | Monoclonal antibodies | Universities and colleges | Laboratories | Lipids | Triglycerides | Lipoproteins | Pain | Influenza | Patient safety | Population | Mutation | Clinical medicine | Diabetes | Statins
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 169, Issue 6, pp. 906 - 915.e13
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10034, pp. 2218 - 2225
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 62, Issue 16, pp. 1432 - 1435
  [...]although the association between CR and survival benefit appears sound, conclusions regarding secondary endpoints of MI or repeat revascularization are... 
Cardiovascular | Internal Medicine | Heart attacks | Drug therapy | Stents | Coronary vessels | Clinical outcomes
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2010, Volume 56, Issue 12, pp. 919 - 933
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 65, Issue 20, pp. 2211 - 2221
Journal Article